Literature DB >> 1713190

Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules.

H S de Koster1, M J Kenter, J D'Amaro, R M Luiten, W E Schroeijers, M J Giphart, A Termijtelen.   

Abstract

The identification of 19 different HLA-DPB1 sequences implicates the existence of more DP specificities than can be typed for with cellular methods. How many of the DP beta sequences can be specifically recognized by T cells, and which of the polymorphic regions can contribute to the specificity of allorecognition, is not known. In order to investigate the distribution and the immunological relevance of recently described DPB1 alleles, we have typed a panel of 98 randomly selected Dutch Caucasoid donors for the HLA-DPB1 locus by oligonucleotide typing. Comparison of the typing results with primed lymphocyte typing (PLT) defined DP specificities shows an extremely good correlation. Moreover, additional alleles could be defined by oligonucleotide typing reducing the number of DP blanks in the panel. By selecting the appropriate responder stimulator combinations we were able to show that distinctive PLT reagents against oligonucleotide defined specificities DPB1*0401, DPB1*0402, DPB1*0901, and DPB1*1301 can be generated. To investigate in more detail which part of the DP molecule is responsible for the specificity of T-cell recognition, T-cell clones were generated against HLA-DPw3. The clones were tested for the recognition of stimulators carrying DPB1 alleles which had been defined by oligonucleotide typing and sequence analyses and which differed in a variable degree from DPB1*0301. The recognition patterns demonstrated that differences of one amino acid in polymorphic regions situated either in the beta sheets or alpha helix of the hypothetical model of the HLA class II molecule can eliminate T-cell recognition. Furthermore, sequence analyses revealed a new DPB1 allele designated DPB1*Oos.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713190     DOI: 10.1007/bf00212307

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  37 in total

Review 1.  Nomenclature for factors of the HLA system, 1989.

Authors:  J G Bodmer; S G Marsh; E Albert
Journal:  Immunol Today       Date:  1990-01

Review 2.  Structure, sequence and polymorphism in the HLA-D region.

Authors:  J Trowsdale; J A Young; A P Kelly; P J Austin; S Carson; H Meunier; A So; H A Erlich; R S Spielman; J Bodmer
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

3.  A "new" supertypic HLA-DP related determinant detected by primed lymphocyte typing (PLT).

Authors:  N Odum; B Hofmann; J J Hyldig-Nielsen; B K Jakobsen; N Morling; P Platz; L P Ryder; A Svejgaard
Journal:  Tissue Antigens       Date:  1987-02

4.  The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens.

Authors:  N Odum; R Hartzman; B K Jakobsen; N Morling; P Platz; F M Robbins; L P Ryder; A Svejgaard
Journal:  Tissue Antigens       Date:  1986-08

5.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

7.  Population studies of HLA-linked SB antigens and their relative importance in primary MLC typing. Analysis of HLA-D homozygous typing cells and normal heterozygous populations.

Authors:  G Pawelec; S Shaw; M Schneider; M Blaurock; M Frauer; D Brackertz; P Wernet
Journal:  Hum Immunol       Date:  1982-11       Impact factor: 2.850

8.  Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex.

Authors:  M Roux-Dosseto; C Auffray; J W Lillie; J M Boss; D Cohen; R DeMars; C Mawas; J G Seidman; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis.

Authors:  A B Begovich; T L Bugawan; B S Nepom; W Klitz; G T Nepom; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Human allograft-derived T-cell lines: donor class I- and class II-directed cytotoxicity and repertoire stability in sequential biopsies.

Authors:  M C Miceli; T S Barry; O J Finn
Journal:  Hum Immunol       Date:  1988-07       Impact factor: 2.850

View more
  6 in total

1.  AB1: a novel HLA-DPB1 allele found in one third of an Australian population.

Authors:  X Gao; A Veale; S Serjeantson
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Nucleotide sequence of a novel HLA-DPB1 allele.

Authors:  J W Dekker; L Croft; S Easteal
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  A new approach to HLA-DPB1 typing combining DNA heteroduplex analysis with allele-specific amplification and enzyme restriction.

Authors:  R Sorrentino; I Potolicchio; G B Ferrara; R Tosi
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  Allelic diversity at the Mhc-DP locus in rhesus macaques (Macaca mulatta).

Authors:  B L Slierendregt; N Otting; M Kenter; R E Bontrop
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes.

Authors:  G M Taylor; A Hussain; T J Lightfoot; J M Birch; T O B Eden; M F Greaves
Journal:  Br J Cancer       Date:  2008-03-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.